Ephraim Resources Limited Share Price

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 10:17:55 28/02/2017 am IST 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation : Ephraim Resources Limited

Market Cap 30.8L 26.54L 24.88L 22.72L 42.79L 29Cr 42.93L 2.95Cr 1.15Cr 15Cr 1.16Cr 1.13Cr 49Cr P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 36.28L 31.27L 29.31L 26.76L 50.41L 35Cr 50.57L 3.48Cr 1.36Cr 18Cr 1.36Cr 1.33Cr 58Cr EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 20.89L
-0.78%-1.42%+2.96%+21.65% 5.05TCr
-6.00%-0.75%+447.48%+535.14% 4.46TCr
-0.24%+0.74%+37.18%+16.26% 4.31TCr
-1.55%-2.07%+19.83%+71.70% 4.17TCr
-0.31%-0.83%+19.47%+48.24% 3.32TCr
-1.79%-3.24%+26.32%+125.06% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.63%+27.62% 1.46TCr
-1.66%-1.25%+78.49%+42.97% 1.39TCr
Average +8.62%+9.05%+80.42%+111.08% 2.75TCr
Weighted average by Cap. -1.70%-1.06%+96.28%+129.03%

Financials

2017 2018
Net sales 16.01T 13.8T 12.93T 11.81T 22.24T 15.3L 22.31T 2L 59.88T 8L 60.11T 58.8T 25.61L 124 106.85 100.18 91.45 172.28 11.85T 172.83 1.19T 463.75 5.98T 465.56 455.43 19.84T
Net income -5L -4L -4L -4L -7L -4.6Cr -7L -46.1L -17.99L -2.32Cr -18.06L -17.66L -7.69Cr -10L -8L -8L -7L -13.55L -9.32Cr -13.6L -93.51L -36.49L -4.71Cr -36.63L -35.83L -16Cr
Net Debt 5L 4L 4L 4L 7L 4.75Cr 7L 47.61L 18.58L 2.4Cr 18.65L 18.24L 7.95Cr 5L 5L 4L 4L 8L 5.24Cr 8L 52.56L 20.51L 2.65Cr 20.59L 20.14L 8.77Cr
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-